CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity

Citation
A. Jekle et al., CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity, BIOC BIOP R, 272(2), 2000, pp. 395-399
Citations number
18
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
272
Issue
2
Year of publication
2000
Pages
395 - 399
Database
ISI
SICI code
0006-291X(20000607)272:2<395:CLCDNB>2.0.ZU;2-2
Abstract
Expression of CD95 ligand on parenchymal, epithelial, or tumor cells has be en suggested to downregulate the immune response and to control lymphocyte activation. Suppression might be mediated by induction of apoptosis or by i nhibition of Ca2+ channels upon CD95 triggering. We, therefore, aimed to em ploy this model to modify the immune response to an antigen presented to cy totoxic T cells by antigen-presenting MC57 cells. This model would be very useful to specifically downregulate the immune response to autoantigens in autoimmune situations. However, cytotoxic T cell lines tested in the presen t study were resistant to CD95 ligand expression on antigen-presenting MC57 cells. In addition, coincubation of the lymphocytes with antigen presentin g cells failed to block cytotoxicity mediated by the T lymphocytes. We, the refore, conclude that single expression of CD95 ligand on antigen-presentin g cells is insufficient to specifically downregulate an immune response by CD8+- triggered immune response. (C) 2000 Academic Press.